Boiron SA
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties compr… Read more
Boiron SA (BOI) - Total Liabilities
Latest total liabilities as of June 2025: €192.47 Million EUR
Based on the latest financial reports, Boiron SA (BOI) has total liabilities worth €192.47 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Boiron SA - Total Liabilities Trend (2001–2024)
This chart illustrates how Boiron SA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Boiron SA Competitors by Total Liabilities
The table below lists competitors of Boiron SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Lang Inc
TW:6165
|
Taiwan | NT$1.61 Billion |
|
Rivco Australia Ltd
AU:RIV
|
Australia | AU$20.63 Million |
|
Naintech Co. Ltd.
KQ:267320
|
Korea | ₩69.33 Billion |
|
Singatron Enterprise Co Ltd
TWO:6126
|
Taiwan | NT$3.26 Billion |
|
Fiera Milano S.p.A.
LSE:0EGH
|
UK | €661.54 Million |
|
Paiho Shih Holdings Corp
TW:8404
|
Taiwan | NT$11.90 Billion |
|
Fonar Corporation
NASDAQ:FONR
|
USA | $54.36 Million |
Liability Composition Analysis (2001–2024)
This chart breaks down Boiron SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.39 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.52 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.34 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Boiron SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Boiron SA (2001–2024)
The table below shows the annual total liabilities of Boiron SA from 2001 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €198.15 Million | -0.28% |
| 2023-12-31 | €198.70 Million | -14.41% |
| 2022-12-31 | €232.15 Million | -2.84% |
| 2021-12-31 | €238.93 Million | -12.37% |
| 2020-12-31 | €272.65 Million | +5.34% |
| 2019-12-31 | €258.82 Million | -7.90% |
| 2018-12-31 | €281.03 Million | -0.66% |
| 2017-12-31 | €282.91 Million | -0.88% |
| 2016-12-31 | €285.44 Million | +2.16% |
| 2015-12-31 | €279.40 Million | -3.54% |
| 2014-12-31 | €289.67 Million | +5.06% |
| 2013-12-31 | €275.73 Million | +22.48% |
| 2012-12-31 | €225.12 Million | +2.82% |
| 2011-12-31 | €218.96 Million | +2.08% |
| 2010-12-31 | €214.50 Million | +2.80% |
| 2009-12-31 | €208.66 Million | +8.76% |
| 2008-12-31 | €191.86 Million | +7.51% |
| 2007-12-31 | €178.45 Million | -1.94% |
| 2006-12-31 | €181.97 Million | -7.80% |
| 2005-12-31 | €197.37 Million | +55.50% |
| 2004-12-31 | €126.93 Million | +28.94% |
| 2003-12-31 | €98.44 Million | +2.27% |
| 2002-12-31 | €96.26 Million | +11.04% |
| 2001-12-31 | €86.69 Million | -- |